Close
Nordic 9Nordic 9

FC Barcelona (investor - Corporate Investor)

Spain
See something wrong or missing? Let us know
Offices:Barcelona
Average round investment:N/A USD
Average number per year:0.0
Distribution: 2024 (1)
Portfolio companies: Spain Made of Genes
Mostly invests in: Spain Spain (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to FC Barcelona

Name Criteria
Switzerland SNGLR Capital
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
France Keensight Capital
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Germany BIF Partners
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Spain Plastigaur
66%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
Denmark Bagger-Sørensen Equity A/S
66%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
United States Ampersand Capital Partners
63%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
United States Decheng Capital
63%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Finland DevCo Partners
63%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
IDO Investments
63%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden Mertiva
63%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Top